OTTAWA, May 31, 2016 /CNW/ - The issue: As a follow-up to a previous advisory , Health Canada is reminding Canadians about the serious risks posed by the unauthorized product "Animal Test,"after identifying additional retailers and a distributor selling the product. This product may pose a serious risk to the health of Canadians. The product is marketed as a dietary supplement and is labelled to contain yohimbine, a prescription drug ingredient.
Locations:
Company |
Location |
Market Action |
Date Added |
BOSS Supplements |
411 Bayfield Street, Barrie, Ontario |
Removal from sale |
March 23, 2016 |
Supplement King |
1250 Brant Street, Unit 91, Burlington, Ontario |
Removal from sale |
May 20, 2016 |
Nutrition Excellence |
1445 Norjohn Court, Unit 3, Burlington, Ontario |
Product recall |
May 30, 2016 |
Popeye's Supplements |
11 William Kitchen Road, Toronto, Ontario |
Removal from sale |
May 30, 2016 |
Body Nutrition Systems |
180 North Front Street, Belleville, Ontario |
Removal from sale |
May 30, 2016 |
Who is affected:
Consumers who have bought or used any of the affected product.
What consumers should do:
Background:
Yohimbine is a prescription drug ingredient. The use of drugs containing yohimbine (either as yohimbine hydrochloride or yohimbe bark extract) may result in serious adverse reactions, particularly in people with high blood pressure, heart, kidney or liver disease. Side effects associated with yohimbine include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, pregnant or nursing women.
How to report side effects to health products to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
What Health Canada is doing:
Health Canada is monitoring the stop sale and product recall. Should additional retailers or distributors of these products be identified, Health Canada will take appropriate action and inform Canadians.
Également disponible en français
SOURCE Health Canada
PDF available at: http://stream1.newswire.ca/media/2016/05/31/20160531_C4818_PDF_EN_703253.pdf
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article